{"schema_version":"secwatch.filing_event.v1","accession":"0001490978-24-000071","form_type":"8-K","ticker":"SDGR","cik":"0001490978","company_name":"Schrodinger, Inc.","filed_at":"2024-07-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.226170+00:00","generated_at":"2026-05-31T14:20:35.205757+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Schrödinger Q2 rev $47.3M (+35% YoY); net loss $54.0M; updates FY guidance","bullets":["Total revenue $47.3M (+35% YoY), software rev $35.4M (+21%), drug discovery $11.9M (+104%). Net loss $54.0M vs income $4.3M YoY.","FY2024 guidance: software rev growth 6-13%, drug discovery $30-35M, op expense growth 8-10%, cash use above FY2023.","Co-founded Morphic to be acquired by Lilly for ~$3.2B; Schrödinger holds 834,968 shares and low single-digit royalties.","Launched predictive toxicology platform with $10M Gates Foundation grant and NVIDIA AI integration.","Pipeline: SGR-1505 Phase 1 data 1H25; SGR-2921 Fast Track, data 2H25; SGR-3515 Phase 1 started, data 2H25."],"urls":{"canonical":"https://secwatch.observer/filing/0001490978-24-000071","json":"https://secwatch.observer/filing/0001490978-24-000071.json","markdown":"https://secwatch.observer/filing/0001490978-24-000071.md","text":"https://secwatch.observer/filing/0001490978-24-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1490978/000149097824000071/0001490978-24-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1490978/000149097824000071/sdgr-20240731.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T14:20:35.205757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}